zika

Funding Alert: Contact Congress for Emergency Funding for Zika

Please contact Congress to urge the immediate passage of a bipartisan emergency supplemental bill for Zika.
Take Action

ASM Acts to Counter Zika Virus Outbreak

The emerging threat of Zika virus infection.
Read

ASM Urges Action to Combat Zika Emergency

Current events linked to the Zika virus make aggressive public health actions and funding to combat this emerging infectious disease more crucial than ever.
Read
New Governance Information
VOTE
Become a member today!
JOIN ASM
Submit Abstracts for ABRCMS
SUBMIT
Register for ABRCMS
REGISTER

bliska james


Dr. Bliska’s research seeks to understand molecular mechanisms that underlie pathogenesis or host protection during host-microbe cell interactions.  In particular, he is interested in studying the activities of virulence factors that promote pathogenesis as well as trigger protective host innate and adaptive immune responses.  The closely related Gram-negative bacteria Yersinia pseudotuberculosis and Yersinia pestis are used as model human pathogens to understand this dual nature of virulence factors.  Y. pseudotuberculosis and Y. pestis are facultative intracellular pathogens and both use a highly conserved type III secretion system to deliver multiple effector proteins into the plasma membrane and cytoplasm of host cells. Numerous experimental approaches, including genetics, cell biology, immunology, structural biology, and functional evolutionary genomics, are used to determine how the type III secretion system and other Yersinia virulence factors work to promote disease or protective immunity.  Specific questions being asked include: How do these bacteria prevent phagosome acidification and survive in macrophages? Which components of the type III secretion system are important for generating protective innate and adaptive immune responses in the host?  How does the activity of one effector impact the immune response to another effector?  Has allelic variation of virulence factors contributed to the process by which a bacterium with low pathogenic potential (Y. pseudotuberculosis) evolves into a bacterium with extremely high pathogenic potential (Y. pestis)?

 

 

 

TPL_asm2013_SEARCH

91205